Stephan Eismann News Today

Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology to unlock RNA drug discovery, announced that the Company has created the first large language model (LLM) leveraging chemical mapping data. In a preprint paper published on bioRxiv, Atomic AI describes ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Dec 15, 2023--

Stanford researchers develop machine learning methods that accurately predict the 3D shapes of drug targets and other important biological molecules, even when only limited data is available.

Determining the 3D shapes of biological molecules is one of the hardest problems in modern biology and medical discovery. Companies and research institutions often spend millions of dollars to determine a molecular structure – and even such massive efforts are frequently unsuccessful.